Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add filters








Language
Year range
1.
Journal of Southern Medical University ; (12): 173-175, 2010.
Article in Chinese | WPRIM | ID: wpr-269597

ABSTRACT

<p><b>OBJECTIVE</b>To investigate the tumor-associated antigen CA125 expression in the serum and cervical and vaginal secretions in women during normal reproductive period, and explore the clinical value of detecting tumor markers in the cervical and vaginal secretions.</p><p><b>METHODS</b>A total of 145 women in reproductive period were divided into 3 age groups (20-29 years, 30-39 years, and over 40 years), and their CA125 levels in cervical secretion, vaginal secretion and serum were detected by automatic electro-chemiluminescent immunoassay.</p><p><b>RESULTS</b>CA125 levels in the cervical secretion, vaginal secretion and serum showed no significant difference between the 3 age groups (P>0.05). In each group, CA125 levels differed significantly between the cervical secretion, vaginal secretion and serum (P<0.001). In the 145 women, the average CA125 level was 497.82 - or + 75.29 U/ml in the cervical secretion, 114.66 - or + 26.40 U/ml in vaginal secretion and 18.06 - or + 3.35 U/ml in serum, showing significant differences between them (P<0.001).</p><p><b>CONCLUSION</b>CA125 expression level is significantly higher in the cervical and vaginal secretions than in the serum in women in normal reproductive period, and its levels in cervical and vaginal secretions can be more sensitive and convenient for early detection of related diseases.</p>


Subject(s)
Adult , Female , Humans , Middle Aged , Young Adult , Biomarkers , CA-125 Antigen , Blood , Metabolism , Cervix Mucus , Metabolism , Vagina , Bodily Secretions
2.
National Journal of Andrology ; (12): 337-339, 2006.
Article in Chinese | WPRIM | ID: wpr-338298

ABSTRACT

<p><b>OBJECTIVE</b>To Explore the effect of oblique preputial island flap for the treating of hypospadias.</p><p><b>METHODS</b>Fifty-one patients were performed one-stage urethroplasty with oblique preputial island flap to repair hypospadias.</p><p><b>RESULTS</b>All cases resulted in a good contour of the penis without any redundancy and a normal anatomic position of slit-shaped urethral meatus. The urination was perfect. Six patients occurred complications (3 cases of urinary fistula, 3 cases of meatal stenosis).</p><p><b>CONCLUSION</b>With extensive scope of materials, reliable blood supply of skin flap, satisfactory appearance of shaping penis and few complications, one-stage urethroplasty with oblique preputial island flap is an effective method to repair hypospadias of penile type and penile-scrotal type.</p>


Subject(s)
Adolescent , Child , Child, Preschool , Humans , Male , Hypospadias , General Surgery , Penis , General Surgery , Surgical Flaps , Urethra , General Surgery
3.
Journal of Southern Medical University ; (12): 1794-1796, 2006.
Article in Chinese | WPRIM | ID: wpr-232781

ABSTRACT

<p><b>OBJECTIVE</b>To investigate the clinical efficacy of levonorgestrel-releasing intrauterine system (LNG-IUS) in the treatment of adenomyosis.</p><p><b>METHODS</b>Seventy patients with adenomyosis diagnosed according to clinical symptoms, magnetic resonance imaging (MRI) findings, laparoscopy and/or color-Doppler ultrasound imaging were treated with LNG-IUS, and the menstrual blood volume, dysmenorrhea, uterine volume, hepatic function and serum lipids were observed and evaluated.</p><p><b>RESULTS</b>In the first month of treatment, the menstrual blood size was reduced significantly to (35-/+12)% of that before treatment (P<0.01), and further to (7-/+4)% in the twelfth month (P<0.01). The average uterine volume was decreased by 18.6% (P<0.05) after the treatment, and dysmenorrhea was obviously relieved or completely disappeared alleviated. The condition of anemia was also improved rapidly, and no obvious side-effects on hepatic function and serum lipids were observed.</p><p><b>CONCLUSION</b>LNG-IUS is an effective and safe therapy for adenomyosis.</p>


Subject(s)
Adult , Female , Humans , Contraceptive Agents, Female , Therapeutic Uses , Endometriosis , Drug Therapy , Pathology , Follow-Up Studies , Intrauterine Devices, Medicated , Levonorgestrel , Therapeutic Uses , Treatment Outcome
SELECTION OF CITATIONS
SEARCH DETAIL